Table 3 Overall survival
Parameter | Total | Dead, n (%) | 3-Year overall survival, % | P-valuea | P-valueb (multivariate) |
|---|---|---|---|---|---|
All patients | 59 | 20 (33.9) | 61 | ||
Age (years) | 0.802 | 0.69 | |||
>35 | 24 | 8 (33.3) | 64 | ||
≤35 | 35 | 12 (34.3) | 60 | ||
Gender | 0.475 | 0.95 | |||
Male | 41 | 15 (36.6) | 57 | ||
Female | 18 | 5 (27.8) | 69 | ||
Initial disease site | 0.159 | 0.68 | |||
Extramedullary | 37 | 9 (24.3) | 72 | ||
Leukemia | 22 | 11 (50.0) | 48 | ||
WBC | <0.0001 | 0.03 | |||
>100 | 12 | 10 (83.3) | 19 | ||
<100 | 47 | 10 (21.3) | 75 | ||
CNS | 0.003 | 0.09 | |||
Positive | 11 | 8 (72.7) | 28 | ||
Negative | 48 | 12 (25.0) | 70 | ||
ETP | <0.0001 | 0.01 | |||
Yes | 9 | 7 (77.8) | 13 | ||
No | 48 | 13 (27.1) | 68 | ||
Missing | 2 | ||||
TdT | <0.0001 | 0.0003 | |||
Negative | 7 | 5 (71.4) | 0 | ||
Positive | 52 | 15 (28.8) | 67 | ||
Karyotype | 0.067 | ||||
Abnormal | 22 | 11 (50.0) | 40 | ||
Diploid | 21 | 6 (28.6) | 71 | ||
Missing | 16 |
